Publication Date:
2014-05-22
Description:
Key PointsFirst-line CPX-351 vs 7+3 control in newly diagnosed AML improves 60-day mortality, remission rate, and OS (HR = 0.46, P = .01) in sAML subset.
Print ISSN:
0006-4971
Electronic ISSN:
1528-0020
Topics:
Biology
,
Medicine